Skip to content
Search

Latest Stories

Sebastian James to step down as Boots Managing Director

Sebastian James to step down as Boots Managing Director

Boots have already started the process of recruiting a new Managing Director

Walgreens Boots Alliance (WBA) has officially announced that Sebastian James, the Managing Director of Boots, will be stepping down from his role to pursue a new opportunity in the healthcare sector.


James has given notice to leave the company and will remain with Boots until November. The UK pharmacy giant has already begun the search for a new Managing Director.

James is set to take on the role of CEO at Veonet, a leading European chain of ophthalmology clinics.

During his tenure as Managing Director since 2018, James played a pivotal role in transforming Boots into the UK’s leading health and beauty retailer.

He oversaw significant growth and innovation, achieving thirteen consecutive quarters of retail market share growth. Most recently, the company announced strong Q3 results in June with growth across all categories.

Sebastian contributed to reinventing Boots' beauty business by introducing hundreds of new brands, refurbishing beauty halls across the UK, and hiring more specialist beauty advisors.

Under his leadership, Boots expanded its healthcare services significantly, now offering over 160 healthcare services to both private and NHS patients.

Ornella Barra, Chief Operating Officer, International at Walgreens Boots Alliance, thanked James for his contributions to the company's success over the years, stating, "His tenure has seen the company transform through a steadfast focus on investment, innovation, and growth into the No.1 health and beauty destination in the UK.

“We thank Sebastian for his commitment, along with the Boots leadership team, to delivering a strong platform for sustainable, long-term growth, and we wish him all the best for his next endeavor."

Commenting on his departure, James remarked: "It has been a pleasure to lead this fantastic company and support its transformation during my time as Managing Director.

“Now in its 175th year, Boots has shaped how people access health and beauty products on the high street, and I am proud to have been part of a business that continues to play a critical role in the UK health and beauty sectors.

“I look forward to seeing the business continue to succeed under its excellent leadership team."

His exit comes as Boots’ parent company, WBA, suspended its plans for a sale or stock market listing of the pharmacy chain.

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less